Clear your calendar - It's going down! Text Blocks kicks off on May 20th, and you're invited to take part in the festivities. Splash HQ (122 W 26th St) is our meeting spot for a night of fun and excitement. Come one, come all, bring a guest, and hang loose. This is going to be epic!

Wed
, 
Jan 
10
 at 
5:00pm
The Lean Startup's Guide to Drug Discovery
Ticket Sales Are Closed
Text goes here
X

A JPM Week Seminar Event

Jan 
09
, 
2019
Apply Here
Text goes here
X
The Lean Startup's Guide to Drug Discovery
Tuesday 
January 
14th 
2020
8:00am
 - 
10:00am

Developing a drug discovery pipeline can create tremendous opportunities for a startup, but it can also be daunting with many pitfalls. Come to the Atomwise breakfast seminar during the JP Morgan Healthcare Conference to learn from a panel of experienced entrepreneurs, investors, and drug discovery experts as they provide startup-tailored advice on resources, new technologies, fundraising, and pathways to success. 


Space is limited - apply for your spot today!



PANELISTS

Clear your calendar - It's going down! You're invited to take part in the festivities. Come one, come all, bring a guest, and hang loose. This is going to be epic!

Jared Friedman

Partner

Y Combinator

Jared is a Partner at Y Combinator. Previously, he was cofounder of Scribd, which was funded by Y Combinator in 2006 and grew to be one of the top 100 sites on the web.

Jon Kluft

VP, Investments Group

Roivant Sciences

Jon joined Roivant in 2016 and leads a team dedicated to identification of new opportunities across several therapeutic areas, including immunology and oncology. Prior to Roivant, he spent several years as a biotechnology analyst at an investment firm and obtained a medical degree from Columbia University.

Daria Mochly-Rosen

Founder and Co-Director

SPARK at Stanford

Dr. Mochly-Rosen founded three biotech companies, including KAI Pharmaceuticals. Her experience translating basic research to drug development efforts led her to found SPARK, Stanford’s translational research program. In its 13th year, SPARK has a 60% success rate each year, as measured by licensed projects to excising companies (14) or startups (40) and/or conducting clinical studies (38), addressing local and global health care needs. The SPARK model has been adopted in 70 institutes on all continents and Mochly-Rosen serves as President and Founder of the SPARK GLOBAL organization.Jon joined Roivant in 2016 and leads a team dedicated to identification of new opportunities across several therapeutic areas, including immunology and oncology. Prior to Roivant, he spent several years as a biotechnology analyst at an investment firm and obtained a medical degree from Columbia University.

Julie Woda

Senior Director, R&D

BioMotiv

Dr. Woda is an experienced biotechnology leader with expertise in translating biologics from preclinical to clinical programs. Dr. Woda worked for 12 years at multiple biotechnology companies, leading technologies through product development towards pharmaceutically acceptable therapeutics. As Director of Translational Research at Juventas, Dr. Woda led all aspects of translational research, including preclinical development, developing GMP manufacturing processes, leading to the successful submission of an IND and approval for a Phase II clinical study of a novel gene therapy product. As Senior Director of Research and Development at BioMotiv, Dr. Woda co-leads a business unit focused on identification and in licensing of novel discoveries and early product development.

Text Block #4

Developing a drug discovery pipeline can create tremendous opportunities for a startup, but it can also be daunting with many pitfalls. Come to the Atomwise breakfast seminar during the JP Morgan Healthcare Conference to learn from a panel of experienced entrepreneurs, investors, and drug discovery experts as they provide startup-tailored advice on resources, new technologies, fundraising, and pathways to success. 


Space is limited - apply for your spot today!



Apply Here
Text goes here
X

 

Location


Developing a drug discovery pipeline can create tremendous opportunities for a startup, but it can also be daunting with many pitfalls. Come to the Atomwise breakfast seminar during the JP Morgan Healthcare Conference to learn from a panel of experienced entrepreneurs, investors, and drug discovery experts as they provide startup-tailored advice on resources, new technologies, fundraising, and pathways to success. 


Space is limited - apply for your spot today!




Contact
RSVP
referral link triangle icon
CONTACT THE ORGANIZER
Google   Outlook   iCal   Yahoo
Sorry, ticket sales have closed.